Numoda Names John Boris CEO and President
The founder of the company, Ann Boris, will serve as Chairman of the Board; Changes Effective December 2013.
PHILADELPHIA - Jan. 31, 2014 - PRLog -- Numoda Corporation today announced that the Board of Directors has unanimously approved changes in senior leadership. Effective December, 2013, John Boris who held the position of Chief Counsel of Numoda for 14 years was promoted to the role of President and Chief Executive Officer. Mr. Boris' appointment is a clear demonstration of Numoda's return to its roots: service, innovation and value creation for its stakeholders.
The appointment follows the announcement that Mary Boris Schaheen is no longer with the Company, effective December 2013. Numoda wishes her well in her future endeavors.
Mr. Boris stated that the code for high performance is attention to improved client services, vendor partnerships and empowering organizational culture. More than ever Numoda will have a sharpened focus on providing value to its clients. Numoda Corporation continues to invest in innovative life science technology.
To drive the transformational change in the company, Numoda has been furthering efforts to assemble a powerful board of directors. Effective December 2013, Ann S. Boris, Founder and former COO of Numoda, serves as Chair and has invited Scott Zelov, Dr. Philip Gerbino and Alan Casnoff, well-regarded businessmen, to the board to help guide the company's future strategies and direction. Numoda's new board of directors is responsible for ensuring the success of the Company's senior leadership and that the executive team possesses the experience, skills and character required to achieve the Company's goals. The new COO is Yeda Mancini, who has been with the company in several roles, over 14 years.
About Numoda Corporation
Numoda is the pioneer of a new model for supporting life sciences companies as they move from clinical development of innovative treatments to ultimate relationships with marketing partners.
Our model aligns with both sponsor and vendor needs, addressing the broader issues that active and complex clinical trials face, by providing integrations and automation of administrative functions.
The Numoda approach – which has been proven across scores of relationships – calls for Numoda to share the risk with promising life sciences companies by assisting in business functions such as budgeting and logistics, and to apply patented information technologies and management expertise to achieve the successful completion of vital clinical trials.
The result is a unique partnership between Numoda's finance, technology, and trial management specialists and innovative companies that, in the process, become better able to develop life-enhancing and life-saving treatments for the health of consumers of the future.
"Numoda" is a registered trademark of Numoda Corporation.
Media Contact: Christopher Mather, Numoda Corporation, 215-238-8881, firstname.lastname@example.org
Page Updated Last on: Feb 01, 2014